Skip to main content
EnglishEnglish
EnglishEnglishArabicArabicChinese (Simplified)Chinese (Simplified)FrenchFrenchGermanGermanHindiHindiPortuguesePortugueseRussianRussianSpanishSpanishSwahiliSwahili

Header

  • Contact us
  • Subscribe to newsletter
Home The Task Force for Global Health logo
  • https://twitter.com/GlobalHep
  • https://www.facebook.com/GlobalHep/
  • https://vimeo.com/globalhep
Donate
Add a Program
Add a Program
Profile
Logout

Main navigation

  • About
    • Who we are
    • What we do
    • Our team
    • Technical Advisory Board
    • Executive Board
    • Donor Acknowledgements
    • CGHE Annual Reports
      • Annual Report 2021
      • Annual Report 2020
  • Programs
    • Programs search
  • Data dashboards
    • Country data dashboards
    • National Hepatitis Elimination Profiles
  • Evidence base
    • All evidence (search)
      • Evidence Base Methodology
    • HCV Treatment in Pregnancy
    • Action Plan Systematic Review
    • Hepatitis B Birth Dose Vaccine Systematic Review
      • Synthesis Brief of Hepatitis B Birth Dose Evidence Base
    • HCV Testing Systematic Review
    • COVID-19 Evidence Hub
      • COVID-19 and Liver Disease Synthesis
      • Clinical Liver Disease COVID-19 special series
        • The COVID-19 Pandemic: An Epidemiologic, Public Health, and Clinical Brief
        • Synthesis of Liver Associations Recommendations for Hepatology and Liver Transplant Care During the COVID-19 Pandemic
    • Innovations in Hepatitis Elimination (CLD Series)
      • Author Interviews
      • Introduction to Series
      • Past Publications
      • Author Guidance
    • Hepatitis Elimination Help Desk
  • Resources
    • Search resources
    • Technical Assistance Help Desk and Frequently Asked Questions
  • Webinars
    • Hep Test
    • Linkage to care
    • Strategic Information Collaborative
    • Regional Hepatitis Elimination
    • HepB Birth Dose Introduction in AFRO
    • Innovations in Hepatitis Elimination
    • NIH Research Advancing Hepatitis Elimination
    • Search webinars
  • Elimination champions
    • Elimination Champions
    • Nominations for Elimination Champions
  • News
    • News search
  • Hep C Elimination Tool
    • Access the Tool
    • User Guide
    • Frequently Asked Questions
  1. Home
  2. Resources
  3. Resources search

Resources search

Filter

  • Hepatitis B
  • Hepatitis C
  • Data
  • Guidelines
  • Implementation
  • National plans
  • Policy
  • Blood safety
  • Coinfection with HIV
  • Community mobilization
  • Harm reduction
  • HCV testing and linkage to Care
  • HCV treatment
  • Hepatitis B Vaccination
  • Hep B birth-dose vaccination
  • Injection safety and infection control
  • Prevention mother-child transmission
  • Strategic data analysis
  • Algeria
  • American Samoa
  • Argentina
  • Armenia
  • Australia
  • Azerbaijan
  • Bangladesh
  • Belarus
  • Brazil
  • Brunei Darussalam
  • Cambodia
  • Cameroon
  • China
  • Congo (Democratic Republic of the)
  • Cook Islands
  • Egypt
  • Ethiopia
  • Fiji
  • France
  • French Polynesia
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Global
  • Greece
  • Guam
  • Hong Kong
  • Hungary
  • Iraq
  • Italy
  • (-) Japan
  • Kazakhstan
  • Kiribati
  • Korea (Republic of)
  • Kyrgyzstan
  • Lao People's Democratic Republic
  • Libya
  • Macao
  • Malaysia
  • Marshall Islands
  • Mauritania
  • Mexico
  • Micronesia (Federated States of)
  • Moldova (Republic of)
  • Mongolia
  • Morocco
  • Myanmar
  • Nauru
  • New Zealand
  • Nigeria
  • Niue
  • Northern Mariana Islands
  • Pakistan
  • Palau
  • Papua New Guinea
  • Philippines
  • Pitcairn
  • Poland
  • Romania
  • Russian Federation
  • Rwanda
  • Samoa
  • Saudi Arabia
  • Singapore
  • Solomon Islands
  • Somalia
  • South Africa
  • Spain
  • Sudan
  • Syrian Arab Republic
  • Taiwan
  • Tajikistan
  • Tanzania
  • Thailand
  • Tokelau
  • Tonga
  • Tuvalu
  • Uganda
  • Ukraine
  • United Kingdom
  • United States of America
  • Vanuatu
  • Viet Nam
  • Wallis and Futuna
  • Yemen

Displaying 1 - 8 of 8

  • Implementation

    Protocol: Prospective observational study aiming for micro-elimination of hepatitis C virus in Nagawa town: The Nagawa Project

    26 Aug 2021
    Kobayashi H et al. PLoS One.
    Hepatitis C
  • Policy

    Do the most heavily burdened countries have the right policies to eliminate viral hepatitis B and C?

    27 Jul 2020
    Palayew A et al. Lancet Gastro Hep.
    Hepatitis B
    Hepatitis C
  • Data

    Trends in the total numbers of HBV and HCV carriers in Japan from 2000 to 2011

    29 Jun 2017
    J Viral Hepat. 2018;25:363–372.
    Hepatitis B
    Hepatitis C
  • Data

    A review of the burden of hepatitis C virus infection in China, Japan, South Korea and Taiwan

    13 Jun 2015
    Hepatology International
    Hepatitis C
  • Policy

    WPRO: Accelerated Hepatitis B Control

    19 Jul 2019
    Hepatitis B
  • Data

    Progress Toward Hepatitis B Control and Elimination of Mother-to-Child Transmission of Hepatitis B Virus — Western Pacific Region, 2005–2017 (MMWR)

    01 Mar 2019
    Hepatitis B
  • National plans

    Regional Action Plan for Viral Hepatitis in the Western Pacific 2016–2020

    19 Jul 2019
    Hepatitis B
    Hepatitis C
  • Guidelines

    Japan basic guidelines for promotion and control measures for hepatitis

    15 Jun 2017
    Euroasian J Hepatogastroenterol. 7(1): 60-64
    Hepatitis B
    Hepatitis C

Contact us

globalhep [at] taskforce.org

Tel: +1-404-371-0466

 

Photos on home page by Tayvessa Wilson, Conor Ashleigh, and Zunaid Murshed Paiker

Support us

Donate

Follow us

  • https://twitter.com/GlobalHep
  • https://www.facebook.com/GlobalHep/
  • https://vimeo.com/globalhep

Sign up to our newsletter

<

Footer

  • Contact
© 2019 - 2022 Coalition for Global Hepatitis Elimination
Website by Manta Ray Media